Geron (GERN) Revenue (2010 - 2026)
Geron's (GERN) quarterly Revenue came in at $57.5 million in Q2 2026, up 17.22% year-over-year from $49.0 million in Q2 2025, and up 10.89% quarter-over-quarter from $51.8 million in Q1 2026.
Analysis
Geron (GERN) Revenue (2010 - 2026) Analysis & Trends
Geron has disclosed Revenue across 17 years of filings, most recently posting $57.5 million for Q2 2026.
- In Q2 2026, Revenue rose 17.22% year-over-year to $57.5 million; the TTM figure through Jun 2026 stood at $243.8 million (up 37.83% YoY), while the FY2025 annual figure was $223.1 million, up 149.52% from the prior year.
- Revenue came in at $57.5 million for Q2 2026 at Geron, up from $51.8 million in the prior quarter.
- In the past five years, Revenue ranged from a high of $87.2 million in Q4 2025 to a low of $21000.0 in Q1 2023.
- Average Revenue over 5 years is $23.5 million, with a median of $593000.0 recorded in 2024.
- Year-over-year, Revenue sank 90.1% in 2022 and soared 260600.0% in 2024.
- Over 5 years, Revenue stood at $103000.0 in 2022, then slumped by 77.67% to $23000.0 in 2023, then soared by 260600.0% to $60.0 million in 2024, then surged by 45.5% to $87.2 million in 2025, then sank by 34.12% to $57.5 million in 2026.
- Per Business Quant data, the three most recent Revenue figures were $57.5 million in Q2 2026, $51.8 million in Q1 2026, and $87.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 206.44 Bn | 192.45 Bn | 7.24 Bn | 10.05 Bn |
| 2 | Gilead Sciences | 179.97 Bn | 176.79 Bn | 6.22 Bn | 7.80 Bn |
| 3 | Vertex Pharmaceuticals | 130.57 Bn | 122.72 Bn | 2.84 Bn | 3.33 Bn |
| 4 | Regeneron Pharmaceuticals | 81.63 Bn | 73.63 Bn | 3.93 Bn | 4.29 Bn |
| 5 | Argenx Se | 60.34 Bn | 55.16 Bn | 1.37 Bn | 1.52 Bn |
| 6 | Moderna | 54.37 Bn | 49.23 Bn | 52.00 Mn | 145.00 Mn |
| 7 | Alnylam Pharmaceuticals | 33.07 Bn | 29.76 Bn | 992.69 Mn | 1.29 Bn |
| 8 | Biogen | 31.84 Bn | 30.55 Bn | 1.96 Bn | 2.74 Bn |
| 9 | Roivant Sciences | 29.49 Bn | 29.49 Bn | 1.16 Mn | 1.44 Mn |
| 10 | Geron | 914.60 Mn | 613.75 Mn | - | 57.48 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 57.48 Mn |
| Mar 31, 2026 | 51.84 Mn |
| Dec 31, 2025 | 87.25 Mn |
| Sep 30, 2025 | 47.23 Mn |
| Jun 30, 2025 | 49.04 Mn |
| Mar 31, 2025 | 39.60 Mn |
| Dec 31, 2024 | 59.96 Mn |
| Sep 30, 2024 | 28.27 Mn |
| Jun 30, 2024 | 882,000.00 |
| Mar 31, 2024 | 304,000.00 |
| Dec 31, 2023 | 23,000.00 |
| Sep 30, 2023 | 164,000.00 |
| Jun 30, 2023 | 29,000.00 |
| Mar 31, 2023 | 21,000.00 |
| Dec 31, 2022 | 103,000.00 |
| Sep 30, 2022 | 297,000.00 |
| Jun 30, 2022 | 73,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 109,000.00 |